Ebola Concerns Divert Flight from Detroit to Canada

An Air France flight scheduled for Detroit was redirected to Canada due to Ebola exposure concerns involving a passenger. The flight left Charles de Gaulle Airport in Paris without adhering to entry restrictions specifically created to mitigate Ebola risks. The U.S. Customs and Border Protection (CBP) stated the passenger, coming from the Democratic Republic of Congo (DRC), should not have been on the plane.

As a precaution, the flight was rerouted to Montreal. The CBP reported taking prompt action to prevent that traveler from entering through Detroit Metropolitan Wayne County Airport.

A travel ban is currently in effect, prohibiting entry into the U.S. by non-U.S. passport holders from DRC, South Sudan, and Uganda. This 30-day ban began on May 18, following confirmation of an Ebola outbreak linked to the Bundibugyo virus in northeastern DRC. Furthermore, Uganda has reported cases imported from DRC.

Although South Sudan has not reported any current outbreak-related cases, it remains a high-risk country according to the U.S. Department of Homeland Security (DHS).

The DHS noted, “To prevent the spread of this communicable disease in the U.S., we are enforcing stronger public health measures, including cooperation from the CDC and other relevant agencies, at key U.S. airports receiving the majority of travelers from DRC, Uganda, and South Sudan.”

Measures intensify as the DHS plans to implement new travel restrictions. According to a draft DHS rule set for Thursday release, flights with passengers from DRC, South Sudan, or Uganda within the past 21 days must land at Washington-Dulles International Airport.

Ebola Outbreak and Public Emergency

The World Health Organization (WHO) announced Ebola as an “international public health emergency.” In response to Newsweek, President Donald Trump expressed concern at a press briefing. The CDC confirmed no Ebola cases in the U.S. and labeled the risk to the public as low.

Dr. Peter Stafford, an American physician with the nonprofit Serge, contracted the Ebola Bundibugyo strain while treating patients in eastern Congo. He was flown to Germany for treatment due to shorter flight duration and Germany’s familiarity with Ebola cases.

As of the most recent reporting, the DRC and Uganda have documented 536 suspected, 105 probable, 34 confirmed cases, and 134 deaths linked to Ebola.

Origins of the Outbreak

At this month’s start, healthcare professionals in Bunia Health Zone, northeastern DRC, fell severely ill. Initial tests were negative for Ebola, but by May 15, eight of 13 samples tested positive for the Bundibugyo virus. This virus is one of the four causing Ebola disease in humans and lacks a vaccine, with treatment focusing on supportive care.

The Bundibugyo virus results in a 30% death rate for infected individuals. During 2014-2016, over 11,000 people perished in the largest West African Ebola outbreak.

This marks the 17th DRC Ebola outbreak since 1976, with the last instance reported in December. The DHS stressed the potential of these epidemics to escalate into global crises without early intervention. Ebola’s medical, public health, and economic repercussions can be significant if the disease reaches high-density areas.

The DHS further warned, “Ebola may pose a threat to U.S. health security due to unpredictable outbreaks and international connectivity.”

Understanding Ebola

Ebola is a severe disease affecting humans and primates, caused by orthoebolaviruses and primarily transmitted through direct contact with an infected individual’s bodily fluids. Bundibugyo, identified in 2007, has been part of two main outbreaks in the past.

Symptoms start with fever, aches, and fatigue as “dry symptoms,” progressing to “wet symptoms” like diarrhea and vomiting. The CDC states symptoms typically appear 8-10 days post-exposure.

While the FDA has approved treatments for the Orthoebolavirus zairense species, other Ebola types, such as the Bundibugyo virus, rely on supportive care methods. These include fluid and electrolyte provision, blood pressure management, fever, and infection treatments.